Retatrutide's 28.7% at 68 weeks closes a two-decade arc that began with every major pharma trying to shut the glucagon receptor off
First, we studied 2 million patients diagnosed with type 2 diabetes who had a healthcare encounter between January 1, 2017, and October 31, 2024
Additionally, Wegovy can help improve metabolic health, including better blood sugar control, making it a suitable option for those with weight-related conditions such as type 2 diabetes or metabolic syndrome
The 72-hour minimum applies equally to all tirzepatide formulations
Consult your doctor for dose adjustments and personalized guidance to manage this side effect
GLP-1 Receptor Agonists GLP-1RA have been found to have several effects in various organs and tissues